Ann Rheum Dis 2001;60:353-358 ( April )

Extended report

Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients A Boonen^a, A Chorus^b, H Miedema^b, D van der Heijde^a, H van der Tempel^c, Sj van der Linden^a

^a University Hospital Maastricht, The Netherlands, ^b TNO-PG, Leiden, The Netherlands, ^c Maasland Ziekenhuis, Sittard, The Netherlands

Correspondence to: Dr Boonen, Department of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands aboo{at}SINT.AZM.NL

Accepted for publication 7 August 2000

OBJECTIVETo evaluate employment status, work disability, and work days lost in patients with ankylosing spondylitis (AS).
METHODSA questionnaire was sent to 709 patients with AS aged 16-60. The results of 658 of the patients could be analysed.
RESULTSAfter adjustment for age, labour force participation was decreased by 15.4% in male patients and 5.2% in female patients compared with the general Dutch population. Work disability (all causes) was 15.7% and 16.9% higher than expected in the general population for male and female patients respectively. In particular, the proportion of those with a partial work disability pension was increased. Patients with a paid job lost 5.0% of work days as the result of having AS, accounting for a mean of 10.1 days of sick leave due to AS per patient per year in addition to the national average of 12.3 unspecified days of sick leave.
CONCLUSIONThis study on work status in AS provides data adjusted for age and sex, and the differences from the reference population were significant. The impact of AS on employment and work disability is considerable. Work status in patients with AS needs more attention as an outcome measure in future research.

---

© 2001 by Annals of the Rheumatic Diseases
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• ARIZA-ARIZA, R., HERNANDEZ-CRUZ, B., COLLANTES, E., BATLLE, E., FERNANDEZ-SUEIRO, J. L., GRATACOS, J., JUANOLA, X., LINARES, L. F., MULERO, J., ZARCO, P. (2009). Work Disability in Patients with Ankylosing Spondylitis. The Journal of Rheumatology 36: 2512-2516 [Abstract] [Full Text]  
• Hamilton-West, K. E., Quine, L. (2009). Living with Ankylosing Spondylitis: The Patient's Perspective. J Health Psychol 14: 820-830 [Abstract]  
• Landewe, R, Dougados, M, Mielants, H, van der Tempel, H, van der Heijde, D (2009). Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis 68: 863-867 [Abstract] [Full Text]  
• Strombeck, B., Jacobsson, L. T. H., Bremander, A., Englund, M., Heide, A., Turkiewicz, A., Petersson, I. F. (2009). Patients with ankylosing spondylitis have increased sick leave--a registry-based case-control study over 7 yrs. Rheumatology (Oxford) 48: 289-292 [Abstract] [Full Text]  
• Li, E. K., Griffith, J. F., Lee, V. W., Wang, Y.-X., Li, T. K., Lee, K. K., Tam, L.-S. (2008). Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation. Rheumatology (Oxford) 47: 1358-1363 [Abstract] [Full Text]  
• Braun, J, Baraliakos, X, Listing, J, Fritz, C, Alten, R, Burmester, G, Krause, A, Schewe, S, Schneider, M, Sorensen, H, Zeidler, H, Sieper, J (2008). Persistent clinical efficacy and safety of anti-tumour necrosis factor {alpha} therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. Ann Rheum Dis 67: 340-345 [Abstract] [Full Text]  
• Barkham, N., Kong, K. O., Tennant, A., Fraser, A., Hensor, E., Keenan, A. M., Emery, P. (2005). The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis. Rheumatology (Oxford) 44: 1277-1281 [Abstract] [Full Text]  
• Listing, J, Brandt, J, Rudwaleit, M, Zink, A, Sieper, J, Braun, J (2004). Impact of anti-tumour necrosis factor {alpha} treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis. Ann Rheum Dis 63: 1670-1672 [Abstract] [Full Text]  
• Boonen, A, van der Heijde, D, Landewe, R, Chorus, A, van Lankveld, W, Miedema, H, van der Tempel, H, van der Linden, S (2004). Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?. Ann Rheum Dis 63: 1264-1268 [Abstract] [Full Text]  
• Chorus, A M J, Miedema, H S, Boonen, A, van der Linden, S. (2003). Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62: 1178-1184 [Abstract] [Full Text]  
• Pham, T, van der Heijde, D, Calin, A, Khan, M A, van der Linden, S., Bellamy, N, Dougados, M (2003). Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group. Ann Rheum Dis 62: 812-816 [Abstract] [Full Text]  
• Braun, J, Pham, T, Sieper, J, Davis, J, van der Linden, S., Dougados, M, van der Heijde, D (2003). International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62: 817-824 [Abstract] [Full Text]  
• Boonen, A, van der Heijde, D, Landewe, R, Guillemin, F, Rutten-van Molken, M, Dougados, M, Mielants, H, de Vlam, K, van der Tempel, H, Boesen, S, Spoorenberg, A, Schouten, H, van der Linden, S. (2003). Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis 62: 732-740 [Abstract] [Full Text]  
• Sieper, J, Braun, J, Rudwaleit, M, Boonen, A, Zink, A (2002). Ankylosing spondylitis: an overview. Ann Rheum Dis 61: iii8-18 [Abstract] [Full Text]  
• Braun, J, van der Heijde, D, Dougados, M, Emery, P, Khan, M A, Sieper, J, van der Linden, S. (2002). Staging of patients with ankylosing spondylitis: a preliminary proposal. Ann Rheum Dis 61: iii19-23 [Abstract] [Full Text]  
• Chorus, A M J, Boonen, A, Miedema, H S, van der Linden, S. (2002). Employment perspectives of patients with ankylosing spondylitis. Ann Rheum Dis 61: 693-699 [Abstract] [Full Text]  
• Boonen, A, Chorus, A, Landewe, R, van der Heijde, D, Miedema, H, van der Tempel, H, van der Linden, S. (2002). Manual jobs increase the risk of patients with ankylosing spondylitis withdrawing from the labour force, also when adjusted for job related withdrawal in the general population. Ann Rheum Dis 61: 658-658 [Full Text]  
• Boonen, A, van der Heijde, D, Landewe, R, Spoorenberg, A, Schouten, H, Rutten-Van Molken, M, Guillemin, F, Dougados, M, Mielants, H, de Vlam, K, van der Tempel, H, van der Linden, S. (2002). Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 61: 429-437 [Abstract] [Full Text]  
• Boonen, A, Chorus, A, Miedema, H, van der Heijde, D, Landewe, R, Schouten, H, van der Tempel, H, van der Linden, S (2001). Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis 60: 1033-1039 [Abstract] [Full Text]  
• Sieper, J, Braun, J (2001). New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy. Ann Rheum Dis 60: iii58-61 [Full Text]